SCHEMBL31133809

SCHEMBL31133809

C[C@](N)(CO)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17802199 1.00
SCHEMBL7194848 1.00
Hydrochloric Acid SCHEMBL20238973 0.97 MEN1 (0.35)
Hydrochloric Acid SCHEMBL19900969 0.97 MEN1 (0.35)
SCHEMBL8950546 0.80
SCHEMBL28122043 0.79 MEN1 (0.47)
SCHEMBL15081070 0.73
Hydrochloric Acid SCHEMBL16236771 0.71 TSHR (0.35)
SCHEMBL2778683 0.71 MEN1 (0.39)
SCHEMBL932253 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688156-A1 LACTAM-CONTAINING IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS Janssen Pharmaceutica NV (BE) 2026-02-11 EP disclosed
WO-2024201322-A1 LACTAM-CONTAINING IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2024-10-03 WO disclosed